Loading insider details...
Latest Form 4 (Nov 10, 2026): Sale of 40,851 SPRO shares, $42.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 10, 2026 | Spero Therapeutics, Inc. (SPRO) | Sale | 40,851 | $42.5K |
| May 7, 2026 | Spero Therapeutics, Inc. (SPRO) | Sale | 25,240 | $63.4K |
| Feb 10, 2026 | Spero Therapeutics, Inc. (SPRO) | Sale | 37,101 | $87.6K |
| Feb 5, 2026 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 249,000 | n/a |
| Nov 13, 2025 | Spero Therapeutics, Inc. (SPRO) | Sale | 40,270 | $95.4K |
| May 7, 2025 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 185,000 | n/a |
| Feb 6, 2025 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 266,139 | n/a |
| Nov 12, 2024 | Spero Therapeutics, Inc. (SPRO) | Sale | 23,351 | $30.6K |
| Feb 6, 2024 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 119,866 | n/a |
| Nov 15, 2023 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 300,000 | n/a |